These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15955372

  • 1. Early use of insulin in type 2 diabetes.
    Eldor R, Stern E, Milicevic Z, Raz I.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S30-5. PubMed ID: 15955372
    [Abstract] [Full Text] [Related]

  • 2. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Jun; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 3. [How to minimize weight gain associated with insulin treatment].
    Philippe J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [Abstract] [Full Text] [Related]

  • 4. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 09; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 5. Insulin detemir: a new basal insulin analogue.
    Soran H, Younis N.
    Diabetes Obes Metab; 2006 Jan 09; 8(1):26-30. PubMed ID: 16367879
    [Abstract] [Full Text] [Related]

  • 6. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA, Palumbo PJ.
    Arch Intern Med; 2006 Jan 09; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract] [Full Text] [Related]

  • 7. Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time?
    Zinman B.
    Am J Med; 2011 Jan 09; 124(1 Suppl):S19-34. PubMed ID: 21194577
    [Abstract] [Full Text] [Related]

  • 8. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ, Cohen H, Chu V.
    J Clin Pharmacol; 2007 Jul 09; 47(7):890-903. PubMed ID: 17585117
    [Abstract] [Full Text] [Related]

  • 9. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY, Ragoobirsingh D, Peter SA.
    Med Hypotheses; 2006 Jul 09; 67(5):1115-20. PubMed ID: 16806731
    [Abstract] [Full Text] [Related]

  • 10. [Intensive insulin therapy].
    Landgraf R, Huber RM, Bachmann A, Lohr R.
    Dtsch Med Wochenschr; 2008 Apr 09; 133(17):901-12. PubMed ID: 18415916
    [No Abstract] [Full Text] [Related]

  • 11. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.
    Exp Clin Endocrinol Diabetes; 2008 May 09; 116(5):282-8. PubMed ID: 18484560
    [Abstract] [Full Text] [Related]

  • 12. Achieve better glucose control for your hospitalized patients.
    Woolever DR.
    J Fam Pract; 2008 Dec 09; 57(12):782-8. PubMed ID: 19080760
    [No Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar 09; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 14. Overcoming barriers to insulin replacement.
    Kuritzky L.
    J Fam Pract; 2009 Aug 09; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract] [Full Text] [Related]

  • 15. The stepwise approach to the management of type 2 diabetes.
    Warren RE.
    Diabetes Res Clin Pract; 2004 Sep 09; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [Abstract] [Full Text] [Related]

  • 16. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V.
    Diabetes Self Manag; 2003 Sep 09; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V.
    Diabet Med; 2008 Aug 09; 25(8):924-32. PubMed ID: 18959605
    [Abstract] [Full Text] [Related]

  • 18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 09; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 19. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L.
    Adv Med Sci; 2006 Jun 09; 51():133-6. PubMed ID: 17357293
    [Abstract] [Full Text] [Related]

  • 20. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ, Zrebiec J.
    Diabetes Metab Res Rev; 2008 Jun 09; 24(4):257-85. PubMed ID: 18232062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.